Clinical-stage Neuro Attune Neurosciences is a clinical-stage medical device company focused on non-invasive neurostimulation, presenting opportunities to position partner-ready clinical evidence, regulatory alignment, and pilot deployments for hospital systems, clinics, and performance centers.

SMB to Mid-Size With a team size of 11-50 employees and revenue in the low millions, target health systems, clinics, and specialty centers that require scalable, cost-effective neurostimulation solutions with quick onboarding and support.

Performance Focus Emphasize outcomes in human health and performance to appeal to athletic, cognitive, and rehabilitation markets, offering use cases that align with performance optimization and non-invasive treatment paradigms.

Tech-Driven Security Leverage Attune's tech stack and cloud-based delivery to propose secure, cloud-enabled workflows, telehealth integration, and compliant data handling to IT and procurement teams in target accounts.

Funding Signals Recent funding activity and modest revenue suggest room for strategic partnerships, milestone-based contracts, and co-development opportunities with larger device manufacturers or clinical researchers seeking scalable neurostimulation platforms.